TNF and inflammatory bowel disease: Consistent with this is the demonstration that blockade of effector cytokines, such as interleukin (IL)-12/IL-23 and tumor necrosis factor (TNF), helps attenuate the detrimental responses in the gut of IBD patients (8–10).